Correction to: Mol Cell Pediatr 5, 6 (2018)
https://doi.org/10.1186/s40348-018-0084-3
Following publication of the original article [1], the author would like to correct the incorrect grant number found in the Funding statement.
Incorrect Funding statement:
“This work was supported by grants from Cura Placida Children’s Cancer Research Foundation and the Wilhelm-Sander Stiftung (2009.901.3). It is part of the Prospective Validation of Biomarkers in Ewing Sarcoma for Personalised Translational Medicine (PROVABES; 01KT1311), Funding Program of the Federal Ministry of Education and Research (BMBF), Germany.”
Correct Funding statement:
“This work was supported by grants from Cura Placida Children’s Cancer Research Foundation and the Wilhelm Sander-Stiftung (2015.028.1). It is part of the Prospective Validation of Biomarkers in Ewing Sarcoma for Personalised Translational Medicine (PROVABES; 01KT1311), Funding Program of the Federal Ministry of Education and Research (BMBF), Germany.
The original article has been corrected.
Reference
- 1.Burdach SEG, Westhoff MA, Steinhauser MF, et al. Precision medicine in pediatric oncology. Mol Cell Pediatr. 2018;5:6. doi: 10.1186/s40348-018-0084-3. [DOI] [PMC free article] [PubMed] [Google Scholar]